Sio Capital Management LLC's Q2 2026 13F: 15 new positions, 31 exits

Form 13F-HR for the quarter ended Jun 30, 2026 · filed Aug 14, 2026 · 57 reported positions · accession 0001214659-26-010311

What changed this quarter

Sio Capital Management LLC's changes in reported equity positions, Q2 2026
Activity Security Weight before Weight now Change Shares Shares %
Reduced ICON PUB LTD CO (ICLR) 4.9% 2.6% −2.3 pts −218K sh −71%
Reduced DIANTHUS THERAPEUTICS INC (DNTH) 4.5% 1.0% −3.5 pts −311K sh −84%
New ALLOGENE THERAPEUTICS INC (ALLO) — 4.7% +4.7 pts +13.32M sh new
New GLOBUS MED INC (GMED) — 4.1% +4.1 pts +302K sh new
Exited CORCEPT THERAPEUTICS INC (CORT) 3.9% — −3.9 pts −675K sh −100%
Exited LIVANOVA PLC (LIVN) 3.9% — −3.9 pts −422K sh −100%
Increased CENCORA INC (COR) 4.6% 8.4% +3.9 pts +72,694 sh +72%
New IDEAYA BIOSCIENCES INC (IDYA) — 3.1% +3.1 pts +480K sh new
New THE CIGNA GROUP (CI) — 2.7% +2.7 pts +57,750 sh new
New VIATRIS INC (VTRS) — 2.6% +2.6 pts +954K sh new
Reduced WAYSTAR HLDG CORP (WAY) 5.7% 3.3% −2.4 pts −716K sh −44%
Reduced ANI PHARMACEUTICALS INC (ANIP) 2.9% 1.4% −1.6 pts −168K sh −63%
Exited EMBECTA CORP (EMBC) 2.4% — −2.4 pts −1.85M sh −100%
Exited ABIVAX SA (ABVX) 2.2% — −2.2 pts −136K sh −100%
New REGENERON PHARMACEUTICALS (REGN) — 1.9% +1.9 pts +18,000 sh new
New BRISTOL-MYERS SQUIBB CO (BMY) — 1.9% +1.9 pts +194K sh new
New MEDTRONIC PLC (MDT) — 1.9% +1.9 pts +143K sh new
Exited HAEMONETICS CORP MASS (HAE) 1.8% — −1.8 pts −221K sh −100%
Exited TELEFLEX INCORPORATED (TFX) 1.6% — −1.6 pts −94,800 sh −100%
Exited BIOMARIN PHARMACEUTICAL INC (BMRN) 1.6% — −1.6 pts −194K sh −100%
Reduced CELCUITY INC (CELC) 3.2% 2.0% −1.2 pts −83,821 sh −43%
New CYBIN INC (CYBN) — 1.5% +1.5 pts +1.3M sh new
Exited STRUCTURE THERAPEUTICS INC (GPCR) 1.5% — −1.5 pts −209K sh −100%
Increased SENSEONICS HLDGS INC (SENS) 0.1% 1.6% +1.4 pts +1.48M sh +1276%
Exited BIOHAVEN LTD (BHVN) 1.4% — −1.4 pts −1.16M sh −100%
Exited MONOPAR THERAPEUTICS INC (MNPR) 1.4% — −1.4 pts −174K sh −100%
Exited CRINETICS PHARMACEUTICALS IN (CRNX) 1.3% — −1.3 pts −250K sh −100%
Reduced SIONNA THERAPEUTICS INC (SION) 1.7% 1.0% −0.7 pts −167K sh −57%
Exited EDGEWISE THERAPEUTICS INC (EWTX) 1.2% — −1.2 pts −269K sh −100%
Exited COMPASS PATHWAYS PLC (CMPS) 1.2% — −1.2 pts −1.51M sh −100%
New TANGO THERAPEUTICS INC (TNGX) — 1.1% +1.1 pts +209K sh new
Increased ZIMMER BIOMET HOLDINGS INC (ZBH) 0.8% 1.9% +1.1 pts +68,832 sh +110%
Increased SANOFI SA (SNY) 1.7% 2.7% +1.0 pts +125K sh +52%
Reduced ABBOTT LABORATORIES (ABT) 2.8% 2.0% −0.8 pts −57,918 sh −31%
Exited QUIDELORTHO CORP (QDEL) 0.9% — −0.9 pts −359K sh −100%
Exited REPLIMUNE GROUP INC (REPL) 0.8% — −0.8 pts −720K sh −100%
Exited ORGANON & CO (OGN) 0.7% — −0.7 pts −866K sh −100%
Reduced VIR BIOTECHNOLOGY INC (VIR) 1.9% 1.9% −0.1 pts −423K sh −28%
Increased ORUKA THERAPEUTICS INC (ORKA) 0.9% 2.9% +2.0 pts +44,622 sh +34%
Reduced OCULAR THERAPEUTIX INC (OCUL) 1.2% 0.9% −0.3 pts −429K sh −44%
Exited DISC MEDICINE INC (IRON) 0.6% — −0.6 pts −65,203 sh −100%
New AVEANNA HEALTHCARE HLDGS INC (AVAH) — 0.5% +0.5 pts +369K sh new
Reduced ZENAS BIOPHARMA INC (ZBIO) 0.9% 0.9% 0.0 pts −123K sh −37%
Exited INTEGRA LIFESCIENCES HLDGS C (IART) 0.5% — −0.5 pts −383K sh −100%
Reduced MAXIMUS INC (MMS) 7.1% 6.6% −0.5 pts −53,558 sh −7%
Increased TYRA BIOSCIENCES INC (TYRA) 3.3% 3.8% +0.5 pts +89,876 sh +15%
Increased GSK PLC (GSK) 3.1% 3.9% +0.9 pts +50,821 sh +13%
Exited PROQR THERAPEUTICS N V (PRQR) 0.5% — −0.5 pts −1.95M sh −100%
Exited SHOULDER INNOVATIONS INC (SI) 0.4% — −0.4 pts −211K sh −100%
Reduced RAPPORT THERAPEUTICS INC (RAPP) 1.7% 2.2% +0.5 pts −59,152 sh −16%

The 50 largest of 77 changes, by size of the trade. Full holdings for this quarter.

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 50.1% of the equity book

Changes in the top 10 this quarter: ALLO entered · GMED entered · GSK entered · IDYA entered · ORKA entered · ICLR left · DNTH left · CORT left · LIVN left · CELC left

# Security Weight before Weight now
1 ANTERIS TECHNOLOGIES GLOBAL (AVR) 4.3% 9.4%
2 CENCORA INC (COR) 4.6% 8.4%
3 MAXIMUS INC (MMS) 7.1% 6.6%
4 ALLOGENE THERAPEUTICS INC (ALLO) 0.0% 4.7% Entered the top 10
5 GLOBUS MED INC (GMED) 0.0% 4.1% Entered the top 10
6 GSK PLC (GSK) 3.1% 3.9% Entered the top 10
7 TYRA BIOSCIENCES INC (TYRA) 3.3% 3.8%
8 WAYSTAR HLDG CORP (WAY) 5.7% 3.3%
9 IDEAYA BIOSCIENCES INC (IDYA) 0.0% 3.1% Entered the top 10
10 ORUKA THERAPEUTICS INC (ORKA) 0.9% 2.9% Entered the top 10
— ICON PUB LTD CO (ICLR) 4.9% 2.6% Left the top 10
— DIANTHUS THERAPEUTICS INC (DNTH) 4.5% 1.0% Left the top 10
— CORCEPT THERAPEUTICS INC (CORT) 3.9% 0.0% Left the top 10
— LIVANOVA PLC (LIVN) 3.9% 0.0% Left the top 10
— CELCUITY INC (CELC) 3.2% 2.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
New SELLAS LIFE SCIENCES GROUP I (SLS) Put 0 1.23M $18.2M
Exited CENTENE CORP DEL (CNC) Put 100K 0 $0
New HIMS & HERS HEALTH INC (HIMS) Call 0 75,000 $2.6M
Exited ELICIO THERAPEUTICS INC (ELTX) Put 11,700 0 $0
Exited OSCAR HEALTH INC (OSCR) Put 3,000 0 $0